pemvidutide vs semaglutide tirzepatide Tirzepatide vs. Semaglutide: Which Weight Loss Medication is Right for You? Advancements in Clinical Research and

Dettelbach and Bennett, 1979)

64.Liu, J

References Papers of particular interest, published recently, have been highlighted as: Of major importance Nguyen K, et al

Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence